Concentrum Wealth Management

Position in GILD — Gilead Sciences, Inc.

CIK 1765387 SAN JOSE, CA

Position in GILD

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$673,771

-$174,156 QoQ

Shares Held

5,333

-12.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

#1,247

of 2,266 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Concentrum Wealth Management holds $3,763,659 across 6 Drug Manufacturers - General names. GILD ranks #3 (17.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	3,991	$1,013,594
2	AMGN	Amgen Inc	1,954	$707,582
3	GILD	Gilead Sciences, Inc. This page	5,333	$673,771
4	ABBV	AbbVie Inc.	2,422	$609,472
5	MRK	Merck & Co., Inc.	3,939	$506,161
6	LLY	ELI LILLY & Co	211	$253,079

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$673,771	5,333	-12.3%	Shares	Sole	2026-08-06
2026-03-31	$847,927	6,084	-28.6%	Shares	Sole	2026-05-04
2025-12-31	$1,046,481	8,526	-4.6%	Shares	Sole	2026-02-04
2025-09-30	$992,229	8,939	+35.3%	Shares	Sole	2025-11-10
2025-06-30	$732,296	6,605	-10.3%	Shares	Sole	2025-08-12
2025-03-31	$825,472	7,367	-39.1%	Shares	Sole	2025-05-07
2024-12-31	$1,117,307	12,096	-22.9%	Shares	Sole	2025-02-13
2024-09-30	$1,314,695	15,681	+191.3%	Shares	Sole	2024-11-13
2024-06-30	$369,327	5,383	-35.8%	Shares	Sole	2024-08-13
2024-03-31	$614,128	8,384	+23.9%	Shares	Sole	2024-05-06
2023-12-31	$548,113	6,766	+6.5%	Shares	Sole	2024-02-13
2023-09-30	$476,093	6,353	—	Shares	Sole	2023-11-08
No filing history on record for this holder in this stock.